Eli Lilly and Co (NYSE:LLY) - Share price - Overview

Stock Report

Eli Lilly and Co LLY

Last Price
$86.07

Day Change
-0.21|-0.24%

As of 21/06/2018
19:10:33 EDT | USD
Minimum 15 Minutes Delay.

Last Close86.28
Day Range85.19 - 86.28
Mkt Cap93.42Bil
52-Wk Range73.69 - 89.09
Yield %2.52
ISINUS5324571083
Volume2,856,410
P/E80.44
P/S3.87
P/CF15.83

Share Price

Financials
201520162017
More ...
Income Statement
Revenue19,958.7021,222.1022,871.30
Operating Income2,916.103,714.603,121.20
Net Income2,408.402,737.60-204.10
Basic EPS2.272.59-0.19
Avg. Diluted Shares Outstanding1,0661,0621,052
Balance Sheet
Current Assets12,573.6015,101.4019,202.10
Non Current Assets22,995.3023,704.5017,379.60
Total Assets35,568.9038,805.9044,981.00
Current Liabilities8,229.6010,986.6014,535.90
Total Liabilities---
Total Equity14,571.3014,007.7011,592.20
Cash Flow
Operating Cash Flow2,772.804,851.005,615.60
Capital Expenditure-1,626.20-1,092.00-2,163.60
Free Cash Flow1,146.603,759.003,452.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Large-Blend

Fiscal Year Ends

December

Employees

40,655
Key Stats
More ...
Price/Earning TTM80.64
Price/Book6.45
Price/Sales TTM3.88
Rev Growth (3 year avg)5.25
EPS Growth (3 year avg)-
Operating Margin % TTM13.65
Net Margin % TTM-0.89
ROE TTM-1.59
Debt/Equity0.86
Dividends
PreviousLatest
More ...
Declared Date08/05/1818/06/18
Ex-Div16/05/1814/08/18
Paid08/06/1810/09/18
Amnt0.560.56
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.